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Accurate knowledge of tissue temperature is necessary for effective delivery of clinical 
hyperthermia in the treatment of malignant tumours. This report compares computer-predicted 
versus measured intratumoral temperatures in 11 human subjects with intracranial tumours, 
treated with a conceptually simple 'conductive' interstitial hyperthermia system. Interstitial 
hyperthermia was achieved by the use of parallel arrays of implanted, electrically heated 
catheters. The tissue was warmed by thermal conduction and blood convection. Simulation of 
intratumoral temperatures was achieved by solving a modified bioheat transfer equation on a 
digital computer using a finite difference method. Comparison of intratumoral temperatures from 
simulations and measured values differed by about ± 0.75 
o
C. Further analysis of computed 
temperature distributions between catheters revealed a rapidly computable relationship between 
the local minimum tumour temperature and nearby catheter power and temperature that accounts 
for effects of varying blood flow. These findings suggest that 'on-line' prediction and control of 
local minimum tumour temperatures are feasible with the conductive interstitial technique. 
 
















The clinical use of hyperthermia therapy for the treatment of malignant tumours has progressed 
gradually during the past 10-15 years. Many institutions have reported dramatic tumour 
regression in patients treated with hyperthermia alone (Crile 1962, LeVeen et al. 1976, 1980, 
Manning et al. 1982, Storm et al. 1979) or in combination with radiation (Dethlefsen and Dewey 
1982, Hahn and Kim 1980, Hornback et al. 1979, U et al. 1980). Despite these successes, the 
ability of local hyperthermia systems to elevate the temperature of tumours to cytotoxic levels 
has remained elusive. Limitations in equipment and instrumentation for heat delivery and control 
has led to the development of 'cold spots', which are areas that do not reach therapeutic levels 
(Oleson et al. 1984, Perez et al. 1988, Nussbaum 1982). A strong correlation has been 
demonstrated between the presence of cold spots in intratumoral temperature profiles and poor 
clinical results in the treatment of spontaneous cancer in pets (Dewhirst et al. 1984). Presumably, 
areas of tumours that do not reach cytotoxic levels, generally accepted to be above 42 °C, remain 
viable after treatment and may, in some cases, even be stimulated to grow more rapidly (Song et 
al. 1980). 
 
One obvious technical solution to the presence of cold spots is simply to increase the power 
delivered until the probability of subtherapeutic temperatures is very low. Unless the tissue 
temperature elevation is uniform and strictly confined to the tumour, however, the price of such a 
solution is the overheating of nearby normal tissue (hot spots) and the possibility of intolerable 
pain, skin ulceration or other complications. Thus, to prevent both undesired cold spots in the 
tumour and undesired hot spots in adjacent normal tissue, precise control of a focused energy 
source is required. Such control has been stubbornly elusive with hyperthermia systems based on 
external microwave, radiofrequency, or even focused ultrasound technology applied to deep- 
seated tumours noninvasively. As a result, interstitial techniques that deposit power directly 
within neoplastic tissue have been increasingly employed (Meyer 1984). 
 
This report describes patient-specific computer simulations of a conceptually simple technique 
for the generation of local hyperthermia with interstitially implanted catheters. Small-diameter 
(22 mm) interstitial catheters containing electrically resistive heating elements are implanted 
directly into a tumour in a uniform pattern with the aid of a template to gauge spacing (Baumann 
and Zumwalt 1989). Heating element lengths are matched to the dimensions of the tumour being 
treated, thereby limiting the power delivery to nearby normal tissue. The catheters are connected 
to a controllable power source, which under computer guidance, is altered to achieve the desired 
catheter temperature. The heating catheter's internal temperature is monitored via an internal 
thermistor. With this technique, energy is deposited only in the internal resistances of the 
catheters, not directly into the tissue. The tissue is warmed indirectly by simple thermal 
conduction and blood convection. This modality is known as interstitial conductive heating 
(Baumann and Zumwalt 1989). This technique produces temperature profiles similar to other 
conductive techniques such as ferromagnetic seeds (Stauffer et al. 1982, 1984). In the present 
study we used a mathematical model of heat transfer in order to describe and predict temperature 
distributions created by the interstitial array of heated catheters during individual patient 




1. The accuracy of the bioheat transfer equation model in the prediction of intratumoral 
temperatures between catheters. 
 
2. Possible useful implantation geometries for heated interstitial catheters. 
 
3. The electrical energy required to achieve therapeutic temperatures. 
 
4. The effects of variations in local blood flow upon temperature distributions, with the aim of 
predicting blood flow changes and minimal tissue temperatures from clinically measurable 
parameters. 
 
2. Computational methods 
 
2.1. Bioheat equation 
 
This study was performed using an iterative method for solving the bioheat transfer equation, 
first described by Pennes (1948), using the technique of finite differences. The partial differential 
equation used to describe the transient heat transfer of a control volume of tissue, small enough 






metq  is the specific rate of metabolic heat production  ( 0 compared with other terms in the 
context of local heat therapy for cancer) 
 
P is the power density delivered to tissue (= 0 for the conductive, interstitial modality) 
 
Kts is the tissue thermal conductivity 
 
T is the temperature of tissue 
 
cb is the specific heat of blood 
 
b is the specific flow rate of blood in capillaries 
 
Tb is the temperature of blood 
 
ts is the mass density of tissue 
 
cts  is the specific heat of tissue 
 




At steady state, which in practice occurs after about 5-10 min of heating, T/t  0, and the 




On determination of boundary conditions for each control volume, the computational formulae 
were determined, using the Cartesian  coordinate system and allowing heat transfer only in the  
x-y plane. This technique modeled temperature distributions in a two-dimensional mid-cross-
section through an array of heated catheters embedded in tissue, for which the catheter separation 
was small with respect to heated lengths of the catheters, i.e. a simplified 'two-dimensional 
model'.  
 
Each control volume had cross-sectional dimensions of x and y. The control volume thickness 
in the z-direction was assumed to be unity, and the volume of each node was 1xy. The 
following is an example determination of the computational formula for an interior node at 
steady state. Heat transfer due to conduction was designated by N, S, E, and W (north, south, 
east and west) around the point of interest P (Figure 1). Energy must be conserved in each 








where KN, S, E, W is the interface conductivity between a volume (N, S, E or W) and volume P 
(Incropera and Dewitt 1981).  
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Figure 1. Control volume of node P for the two-dimensional coordinate model. 
 
 
Thus, combining Equations (3) to (8), and dividing by the volume, a discretized equation is 
developed for the temperature at point P as a function of the surrounding temperatures and local 






To simplify the expression one may assume all thermal conductivities are of equal value, K and 










The computational formulae for control volumes with different boundary conditions were 
determined in a similar fashion. 
 
Using the bioheat transfer equation in the form of Equation (11), our computational strategy was 
to assume an initial thermal profile and update that estimate by successive iteration. The initial 
thermal profile was chosen as an exponential decay in temperature from each heating catheter. 
This selection is not mandatory to ensure convergence of the model; however, a good estimate of 
the temperature profile will decrease the computational time required to achieve the solution. 
When the difference between temperature estimates from one iteration to the next approaches 
zero, convergence to the steady-state solution is indicated. To further increase the rate of 
convergence, a method of successive over-relaxation (SOR) (Torrance 1985) was employed. 
This method adds a fraction of the difference between the current estimation and the previous 




Selection of the constant, , is limited to the interval [0, 1]. Proper selection of , determined 
either by trial-and-error or analytically (Torrance 1985), allows for much faster convergence. 
 
2.2. Resolution of simulations 
 
In order to achieve accurate predictions of tissue temperatures in the presence of steep thermal 
gradients, the selection of the proper grid size proved to be very important. In exploratory 
calculations the number of grid points was slowly increased until there was negligible difference 
between plotted temperature profiles. A reasonable execution time (3-4 hours) on a Gould NP1 
super-minicomputer was achieved with about 4000 nodes/cm
2
 of simulated tissue. By these 
criteria a full three-dimensional simulation of the tissue would be unrealistic, requiring a 
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computation time > 10
6
 days on the NP1 for a 9 x 9 x 9 cm volume of tissue. Hence, the 
modified two-dimensional simulations described above were performed for 11 patients and 14 
treatment cycles to test the accuracy of the computational simulation of tissue temperatures 
during conductive interstitial heat therapy by comparing computed versus measured 
temperatures, and to explore approaches to future prediction and control of intratumoral 
temperature distributions. 
 
Because the two-dimensional model presented above does not include the heat loss in the 
'vertical' (z) direction, a single-catheter, three-dimensional model based on cylindrical  
coordinates was also developed to estimate such losses for catheters of different effective 
lengths. Comparison of results obtained from the two- and three- dimensional models allowed 
the vertical power loss to be quantified, for any given catheter spacing. This estimated vertical 
heat loss could then be added into the two-dimensional simulation to obtain a quasi-three-
dimensional simulation without the computational cost of a full three-dimensional simulation. 
 




The 11 patients included in this report were treated with conductive interstitial hyperthermia 
between May and October 1988. There were seven men, ages 43-67 years and four women, ages 
40-51 years. The tumour types diagnosed at the time of therapy included six glioblastoma 
multiformes, three anaplastic astrocytomas and two metastatic lesions. All patients were treated 
at Missouri Baptist Medical Center or St Luke's West Hospital in St Louis, Missouri, with 
approval from their Institutional Review Boards (IRB) and an investigational device exemption 
from the US Food and Drug Administration. 
 
Patient selection criteria included local tumour recurrence after the application of appropriate 
standard therapy and an age greater than 15 years. All patients had conventional therapy prior to 
hyperthermia treatment, consisting of either surgery, radiation, brachytherapy, chemotherapy or 
some combination thereof. In all cases, hyperthermia treatment was initiated because other 
treatments failed to control the tumour. No concomitant therapy was given during hyperthermia. 
 
3.2. Hyperthermia therapy 
 
Hyperthermia was delivered according to a treatment protocol which consisted of one to three 
separate hospital admissions for multiple hyperthermia treatments (called treatment cycles). 
Subsequent treatment cycles were prescribed if the tumour continued to show contrast 
enhancement on the computed tomographic (CT) scans. Each treatment cycle consisted of 
delivery of hyperthermia 3 hours out of every 4 hours, six times a day until a total of 72 hours of 
hyperthermia had been delivered. 
 
The hyperthermia catheters were implanted with a nominal 15 mm intercatheter spacing and 
triangular symmetry (Figure 2). A 15 mm intercatheter spacing allowed for satisfactory tissue 
temperatures and implantation. The number of catheters implanted varied with tumour size. 
Thus, each patient treatment was tailored to the tumour size and location. The number of heating 
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catheters implanted ranged from 6 to 17, with a median value of 11. In order to measure tumour 
temperatures between the heating catheters, small (OD 1.2mm) diameter temperature sensing 
(thermistor) probes were implanted as shown in Figure 3. Each temperature sensing probe 
contained four thermistors, spaced 1 cm apart. A minimum of two, and a maximum of 10, 
temperature-sensing probes were implanted with an average of four probes per patient and a total 
of 56 independent tissue temperature measurement sites. The temperatures measured by these 
stationary thermistor probes, in the steady state, were used as comparison points in the computer 





Figure 2. Nominal implantation geometry for heating catheters as seen in cross-section 







Figure 3. Nominal implantation of temperature-sensing catheters and heating 
catheters. Each temperature-sensing catheter is implanted in the centre of three 
heating catheters to measure the minimum tissue temperature. 
 
 
In order to compare accurately temperatures measured by the implanted thermistor catheters, and 
accurately model the implantation of the heating catheters, non-overlapping sequential CT scans 
3 mm thick were employed to obtain implantation geometries. Using the CT scan computer, 
intercatheter distances were determined for multiple points along the axes of the catheters. These 
distances were used as inputs into the computer simulation to accurately represent patient 
treatments. This technique allowed a more precise determination of the implanted catheter 
locations, thereby allowing a more precise model to be implemented. This high-resolution CT 
information was obtained in 11 patients, for whom 14 treatment cycles were included in the 
present analysis. 
 
After implantation, each patient was awakened and transferred to the neurosurgical intensive 
care unit for recovery and subsequent treatment. After a complete neurological assessment, 
treatment parameters were entered into the hyperthermia treatment system computer (Volumetric 
Hyperthermia Treatment System-Cook, Inc., Bloomington, Indiana). Treatment parameters 
included patient data, location and heating section length of each implanted catheter, target 
catheter temperature, number of treatment fractions and the duration of each fraction. After 
preparing the patient for treatment, the implanted catheters were connected to the hyperthermia 
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generator and treatment commenced. During the course of treatment the delivered catheter 
powers and internal temperatures were continuously monitored and stored on magnetic disk for 
later data analysis. 
 
3.3. Off-line simulation of tissue temperatures 
 
Clinically obtained catheter powers, temperatures and initial perfusion estimates were used as 
inputs for the computer simulations. Other inputs included the dimensions of the heating area, 
control volume size, tolerance for determination of convergence and the value of , as well as 
arterial blood temperature. Measured temperatures from the sensing catheters (non-heating) were 
then compared with corresponding simulated temperatures at the CT-verified locations. 
 
Since the actual values of tissue perfusion in each patient were unknown, the following method 
was used to establish perfusion values. This method is based on the strong dependence of the 
change in heating catheter temperature per unit of applied power on the local blood perfusion 
near each catheter, demonstrated by the bioheat transfer equation and noted in general by others 
(Jain and Ward-Hartley 1984). The entire simulation volume was mapped into perfusion regions 
around each catheter (Figure 4). To determine the location of perfusion boundaries, a simple 
distance method was employed. The distance from a control volume to nearby catheters was 
determined and the node was assigned to the perfusion region of the closest catheter. An example 
of typical perfusion boundaries appears as Figure 4. Perfusion was estimated for each region by 
guided trial-and-error, in which successive perfusion values were tested in simulation to identify 
the specific perfusion value that allowed simulated catheter temperature and power dissipation to 
best match those actually measured in the clinic. 
 
 




Specifically, an initial reasonable guess for perfusion in each region was made and the computer 
simulations were allowed to run to convergence with input catheter powers equal to those 
measured clinically. Simulated catheter temperatures were then compared with the measured 
catheter temperatures for the selected perfusion values. The differences between measured and 
computed temperatures were used to update the perfusion estimates, for the perfusion zone 
around each catheter, and then the entire simulation was performed again. This iterative method 
was employed until the difference between the clinically measured and computer-simulated 
catheter temperature was less than 0.25 °C for each catheter. The resulting perfusion values, 
which reproduced the clinically measured set of 11 T/P ratios for each catheter, were those used 
in the 'final' simulation of steady-state temperature distributions for a given patient treatment 
session.  
 
Although this technique does not allow exact determination of local perfusions, since there may 
be blood flow variations along the catheter axis, it does allow determination of a perfusion rate 
that duplicates the heat flux found in the clinic. Simulated temperatures were then compared with 
measured tumour temperatures from implanted sensors (non-heating catheters) at known sites. 
The locations of the temperature sensors were determined from the CT scans, and the simulation 
temperature matrix was searched for the corresponding locations allowing direct comparisons of 
simulated and measured temperatures. The accuracy and precision of simulated temperatures 
were then assessed by histogram analysis of the distribution of difference terms,  




Simulated and measured temperatures were analysed for 11 human subjects at a total of 56 
discrete measurement sites. Figure 5 presents a hidden line plot of a typical temperature matrix 
determined from the computer simulation. Without correcting for 'vertical' heat loss (in the z-
direction), we found the bioheat transfer equation model overestimated measured tumour 
temperatures with a mean error of 1.1 
o
C and a standard deviation of 1.3 
o
C. Figure 6 presents 






Figure 5. A temperature matrix from a typical treatment simulation. The high peaks 
correspond to the catheter temperatures and the lower valleys represent local minima 
in tumour temperature. Zero corresponds to arterial temperature. The temperature of 
each catheter was independently set to achieve the same valley temperature between 




Figure 6. Histogram of temperature errors from direct comparison of measured and simulated 




Using the single-catheter, three-dimensional simulation we found that the heat loss in the vertical 
(Z) direction was, as expected, a function of both the catheter heating element length and the 
local perfusion. The amount of vertical heat loss was found to lie within 4-50% of total power 
dissipated. For a long catheter heating section (8 cm) and a low perfusion (1 ml/min per 100 g) 
the vertical heat loss was only about 4% of the total delivered power. However, with a short 
catheter heating section (2 cm) and a high blood flow rate (70 ml/min per 100 g) up to 50% of 
the delivered power was lost vertically. Applying the perfusion estimate from the two-
dimensional simulation and the corresponding vertical heat loss found from the three-
dimensional simulation, it was found that the resultant quasi-three-dimensional bioheat transfer 
equation again overestimated the measured temperatures, but the mean difference dropped to 0.3 
o
C with a standard deviation of 0.9 °C. Figure 7 presents the histogram of the difference terms 
with simulated temperatures computed by the modified model. Direct comparison of Figures 6 
and 7 shows the marked advantage of the modified two-dimensional method in this particular 
problem. Figure 8 presents a comparison of the predictive value of the two-dimensional and 
quasi-three-dimensional models. On reviewing the simulated temperature profiles, we discovered 
that the overall temperature distributions were surprisingly uniform. Except for a thin sleeve of 
tissue surrounding each catheter heating element, broad, relatively flat zones of temperature 
elevation were achieved between the catheters, the levels of which were highly dependent on 
local perfusion (Figure 5). The greater the local blood flow, the lower the intercatheter 
temperatures. From the computer simulations a polynomial relationship was discovered between 
the ratio of catheter temperature elevation to catheter power and local perfusion. Figure 9 




Figure 7. Histogram of temperature errors from direct comparison of measured and 







Figure 8. Comparison of two-dimensional and quasi-three-dimensional errors in 
temperature prediction. Notice that over 80% of all points (0.80 cumulative frequency) 
occur for the quasi-three-dimensional model at about 1 
o
C error, while in the two-
dimensional model about 60% of all points lie within 1 
o
C error. The dashed curve 




Figure 9. Catheter power per centimetre versus perfusion. For each catheter 






The use of hyperthermia in the treatment of malignant tumours is based on a strong biophysical 
rationale. It is known that hyperthermia kills cells exponentially as a function of time and/or 
temperature. As a result, when temperature remains near the thermal death threshold, small 
differences in temperature can lead to large differences in cytopathological effect. A mere 1 
o
C 
change in treatment temperature can make a significant difference in the incidence of cure or 
recurrence (Sapareto 1982). Because effective treatment of cancer with hyperthermia is 
dependent on the abolition of cold spots (Dewhirst et al. 1984), more accurate and precise 
control of tissue temperatures during therapy is highly desirable.  
 
The ability to predict tissue temperatures from clinically available data is a requisite first step to 
one technically attractive route to this goal: computer-assisted closed-loop controllers for 
hyperthermia applicators. According to this strategy a computer system would predict minimum 
tumour temperature from automatically measured patient data, and adjust input power repeatedly 
until the predicted minimum intratumoral temperature achieved the desired therapeutic target. 
The present investigation demonstrated that, in the case of the conductive interstitial modality at 
least, tissue temperatures may be predictable with sufficient accuracy and precision, to allow 
engineering work to proceed on closed-loop feedback control. In particular, for a given catheter 
spacing and catheter power, it appears possible to predict minimum tissue temperatures near each 
catheter from simple polynomial functions that can be determined in advance of treatment (in 
computations that take many hours) by solving the bioheat transfer equation for commonly used 
catheter spacings and geometries. These rapidly computable polynomials can be incorporated 
into software for on-line control during therapy.  
 
This approach obviates the need for solving the complete bioheat transfer equation on-line, a task 
still often beyond the capabilities of present-day super-computers. The technical difficulties 
involved in eradication of cold spots without overheating adjacent normal tissue have been great 
barriers to the use of hyperthermia as a single-modality treatment of cancer. However, the results 
of this study show that with conceptually simple interstitial conductive heating, the possibility 
exists to predict and control minimum tumour temperatures, even in the presence of time-varying 
and non- uniform blood flow. This modality may also decrease the probability of trauma to the 
patient by minimizing the number of temperature-sensing catheters that must be implanted. 
Another possible advantage of this technique is the ability to tailor the thermal distributions to an 
irregular tumour volume. 
 
This study found the bioheat transfer equation to be a good model for simulating temperature 
distribution in human patients, and with the quasi-three-dimensional technique presented results 
could be further improved. These results are consistent with results in previous reports (Charny 
and Levin 1988, Clegg and Roemer 1985, Olesen et al. 1984, Pantazatos and Chen 1978). 
Prediction and control of minimum intratumoral temperatures are important if neoplastic disease 
is to be treated successfully with hyperthermia. Direct measurement of complete temperature 
distributions cannot be achieved because of the large number of implanted temperature sensors 
required. However, continuous monitoring of input from a limited number of implanted catheters 
is possible with current technology. Numerical reconstruction and prediction of tissue 
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temperatures when applied to the relatively simple conductive interstitial modality become 
tractable for clinical use, and can be further reduced to the essential predictions of potential cold 
spots in the span of a few seconds. The application of these results may represent an important 
development for hyperthermia treatment, allowing tissue temperatures to be adjusted rapidly 
with a limited number of implanted elements. The accuracy and precision of these predictions 
seem sufficient for on-line closed-loop control for adjusting power to underheated regions in a 
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